Business

Orphan Drug Designation Granted by U.S. FDA For Anal Cancer

Orphan Drug Designation Granted by U.S. FDA For Anal Cancer

Invion Ltd.August 20, 20255

Orphan Drug Designation Granted by U.S. FDA For Anal Cancer

About this update from Invion Ltd.

Invion Ltd has released a press release. View Attachment

View stock analysis, news, and events for Invion Ltd.

More from Invion Ltd.

Appendix 4C and Quarterly Activities Report - June 2026

July 30, 2026

Photosoft Platform Expands to Eye Diseases Via Partnership

May 18, 2026

All Invion Ltd. news →